跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ACT ESCITALOPRAM ODT
Authorized
STANDARD
ACT ESCITALOPRAM ODT
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
aa9be500c06f2619
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
aa9be500c06f2619
Drug Approval Canada Name
ACT ESCITALOPRAM ODT
Product Name
ACT ESCITALOPRAM ODT
Status
Marketed
Status Date
2020-05-01
Original Market Date
2016-08-17
Din
02454297
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB10 ESCITALOPRAM
Atc Name
n 06 ab 10
Aig Number
0150435002
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
ESCITALOPRAM
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
aa9be500c06f2619
Type
Standard
Back to Health Canada Approvals
ACT ESCITALOPRAM ODT - Health Canada Drug Approval Details